
Rio Health, a quick commerce platform for medicines and healthcare essentials, has successfully raised ₹43.08 crore (₹43 crore or $4.5 million) in a pre-Series A funding round led by Version One Ventures. According to its regulatory filings accessed by Entrackr, the company's board approved the allotment of 7,130 compulsorily convertible preference shares (CCPS) at an issue price of ₹60,415 per share. Version One Ventures led the round with an investment of ₹21.30 crore, followed by Xeed Ventures with ₹11.84 crore, Good Capital Fund II with ₹9.47 crore, and Amplify IV PCC with ₹47 lakh. This brings the company's total funding to ₹62.24 crore, following earlier rounds that raised ₹19.16 crore. The company's post-money valuation stood at around ₹170 crore following the latest allotment.
Following the latest allotment, Xeed Ventures holds the largest stake at 21.11%, followed by Good Capital at 17.07% and Version One Ventures at 12.86%. Co-founders Ankur Agrawal and Amit Ahuja hold 17.50% each in the company. The fully closed, all-equity round also saw participation from existing investors Xeed Ventures, Good Capital and Amplify, demonstrating strong confidence from both new and existing stakeholders in the company's growth trajectory.
The company plans to utilize the fresh funds to significantly expand its presence across Delhi-NCR (National Capital Region), growing its network from three to more than 15 dark stores. As reported by Entrackr, the funding will support Rio.ai as it expands its AI-driven healthcare and quick-commerce platform. The fresh funds will be used to expand Rio Health's presence across Delhi NCR, grow its network from three to more than 15 dark stores, and strengthen the technology behind its ordering, inventory and delivery operations. Each Rio Health dark store currently serves a radius of approximately three kilometres, with the company using neighbourhood-level demand data to forecast medicine requirements and stock accordingly. The company is targeting an annual run rate of more than ₹150 crore over the next nine to 12 months.
Rio Health currently processes more than 30,000 orders per month, with an average order value ranging between ₹600 and ₹700. According to the company's data, nearly 80% of orders come from repeat customers, demonstrating strong customer retention. The platform offers more than 20,000 stock-keeping units, with long-tail medicines sourced through its distributor network. Founded by Ankur Agrawal and Amit Ahuja, the company delivers medicines and healthcare essentials across Delhi-NCR in 20-30 minutes through its AI-powered platform that enables users to order medicines and healthcare essentials through WhatsApp.
Rio Health's AI-led system identifies prescribed products and creates orders, which are then checked by a licensed pharmacist. Customers can order by speaking or typing in Hindi, English or Hinglish, or by uploading a photograph of a prescription. The platform allows customers to order by speaking or typing in Hindi, English or Hinglish, or by uploading a photograph of a prescription. The company's AI-led system identifies prescribed products and creates the order, which is then checked by a licensed pharmacist. The funding will support Rio.ai as it develops its AI-powered healthcare platform that enables users to order medicines and healthcare essentials through WhatsApp, with reported delivery times of 15-30 minutes.